- Home
- DTIL vs AMPY Comparison
DTIL vs AMPY Comparison
Compare DTIL & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTIL | AMPY |
|---|---|---|
| Founded | 2006 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.9M | 199.8M |
| IPO Year | 2019 | 2011 |
Fundamental Metrics
Financial Performance| Metric | DTIL | AMPY |
|---|---|---|
| Price | $7.08 | $4.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $29.40 | $7.75 |
| AVG Volume (30 Days) | 214.0K | ★ 444.4K |
| Earning Date | 11-03-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 232.26 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,070,000,000.00 | $208,637,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.75 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.53 | $3.65 |
| 52 Week High | $9.62 | $6.79 |
Technical Indicators
Market Signals| Indicator | DTIL | AMPY |
|---|---|---|
| Relative Strength Index (RSI) | 55.09 | 42.72 |
| Support Level | $6.62 | $4.18 |
| Resistance Level | $7.12 | $4.63 |
| Average True Range (ATR) | 0.46 | 0.16 |
| MACD | 0.14 | -0.01 |
| Stochastic Oscillator | 61.67 | 11.63 |
Price Performance
Historical ComparisonAbout DTIL Precision BioSciences Inc.
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The companies oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.